Skip to main content
Erschienen in: Clinical Research in Cardiology 8/2010

Open Access 01.08.2010 | Review

Definitions and incidence of cardiac syndrome X: review and analysis of clinical data

verfasst von: I. A. C. Vermeltfoort, P. G. H. M. Raijmakers, I. I. Riphagen, D. A. M. Odekerken, A. F. M. Kuijper, A. Zwijnenburg, G. J. J. Teule

Erschienen in: Clinical Research in Cardiology | Ausgabe 8/2010

Abstract

There is no consensus regarding the definition of cardiac syndrome X (CSX). We systematically reviewed recent literature using a standardized search strategy. We included 57 articles. A total of 47 studies mentioned a male/female distribution. A meta-analysis yielded a pooled proportion of females of 0.56 (n = 1,934 patients, with 95% confidence interval: 0.54–0.59). As much as 9 inclusion criteria and 43 exclusion criteria were found in the 57 articles. Applying these criteria to a population with normal coronary angiograms and treated in 1 year at a general hospital, the attributable CSX incidence varied between 3 and 11%. The many inclusion and exclusion criteria result in a wide range of definitions of CSX and these have large effects on the incidence. This shows the need for a generally accepted definition of CSX.

Introduction

The syndrome of angina pectoris with a normal coronary arteriogram, often termed cardiac syndrome X (CSX), is an important clinical entity [65]. About 20% of patients with anginal chest pain have normal coronary angiograms (CAG). Some physicians regard this as sufficient to diagnose CSX, the so-called broad diagnosis of CSX [65, 66]. However, the cause of CSX is not conclusively established and its definition is controversial. For example, a subgroup of these patients have objective signs of ischaemia, such as the classic downsloping ST-segment depression on exercise testing and/or a reversible defect detected by myocardial single-photon emission computed tomography (SPECT). Consequently, other authorities consider that CSX is discounted by a positive result from any diagnostic test for ischaemia, especially SPECT; and there is also the view that CSX might best be relabelled as one of several causes of microvascular dysfunction [37]. Furthermore, there are various exclusion criteria, such as hypertension and diabetes, that may or may not be used to discount the diagnosis of CSX. Finally, in overviews and textbooks it is often stated that (pre-menopausal) women are especially prone to developing cardiac syndrome X. In fact, some authors exclusively study female patient populations, but there is considerable variation in the proportion of women in other studies of CSX patients.
The present paper is a review to determine the gender and main definitions for CSX in the recent literature and also the effects of different definitions upon the attributable CSX incidence. To study this latter aspect we examined and analysed the CAG data for a population of patients treated in a general hospital in the Netherlands.

Methods

CSX definitions

The PubMed database was used to identify papers in which criteria and definitions for CSX are described. Our search consisted of ‘(cardiac syndrome x[tiab]) NOT (case reports[pt] OR comment[pt] OR review[pt])’, with limits set to English language, humans, and publication date between June 2003 and July 2008. We limited our search strategy to cardiac syndrome X and excluded metabolic syndrome X and tako-tsubo cardiomyopathy [6, 24, 42].
This search yielded 112 references. Conference abstracts, pediatric papers, and ‘epublications ahead of print’ were excluded. Of 83 articles the full text was retrieved for further analysis. Articles were independently surveyed by two authors (IV and GT) and reviewed with regard to their used definitions of CSX. The survey left 57 studies for this review.

Impact of CSX definition upon CSX incidence

All the CAGs made in 2003 in a general hospital (Spaarne Hospital Hoofddorp, The Netherlands) were collected. An extensive search was made to obtain the clinical history, physical examination, routine laboratory tests, and echocardiography results for all patients with CAGs stated to be completely normal. All CAGs were independently evaluated by two experienced observers (AK and DO).
Only patients with original angiograms and sufficient clinical data were included in the present study.

Results

CSX definitions

The 57 papers selected for determining the main definitions of CSX covered a total of 2,375 patients. A normal coronary angiogram was used in the majority of the studies. However, in a few studies minimal coronary artery disease, like atheromatous plaque without critical obstructions, is included as “normal coronary angiogram” [18, 22, 56]. A few studies state minimal coronary artery disease in the exclusion criteria [1]. But in the majority of the studies there was no statement regarding minimal artery disease. Only few studies specified the interpretation of the normal coronary angiograms, like revision of the CAG films, blinded observation, or interpretation by more reviewers.
Table 1 lists the nine CSX definitions, and hence inclusion criteria, obtained from our review of the 57 studies.
Table 1
Inclusion criteria for CSX
Inclusion criteria for CSX
Number of studies
Angina pectoris
18
Positive exercise stress test
Normal coronary arteries
Effort induced angina pectoris
17
Positive exercise stress test
Normal coronary arteries
Angina pectoris
11
Positive exercise stress test OR positive SPECT
Normal coronary arteries
Angina pectoris
4
Normal coronary arteries
Angina pectoris
4
Positive exercise stress test AND positive SPECT
Normal coronary arteries
Angina pectoris
1
Positive exercise stress test
No significant CAD on CAG
Effort induced AP
1
Positive exercise stress test
Normal coronary arteries AND prolonged coronary flow on CAG
Angina pectoris
1
Positive exercise stress test
Normal coronary arteries AND reduced LVEF on echo
Angina pectoris
1
Positive SPECT
Normal coronary arteries
CSX cardiac syndrome X; AP angina pectoris; CAG coronary angiogram; SPECT single photon emission tomography; LVEF left ventricular ejection fraction
In more detail:
  • Out of the 57 studies 42 required positive exercise electrocardiograms for the diagnosis of CSX. The general criterion, when given, for a positive exercise stress test result was uniform ST depression ≥1 mm. Only one study considered stress-induced angina without significant ST depression to be positive for ischaemia [15].
  • As much as 11 studies regarded positive myocardial perfusion images to be good alternatives to a positive result from exercise testing.
  • As much as 18 studies considered effort-induced angina pectoris as an inclusion criterion.
  • Four studies defined CSX simply as angina pectoris and normal CAG, the so-called broad diagnosis of CSX.
Table 2 lists no less than 43 exclusion criteria for CSX. The most frequently used exclusion criteria are valvular heart disease, diabetes mellitus, left ventricular hypertrophy, hypertension, and cardiomyopathy.
Table 2
Exclusion criteria included studies
Exclusion criteria used in the studies for present review
N studies of 57 total
Valvular heart disease
33
Diabetes mellitus
32
Left ventricular hypertrophy
26
Hypertension
24
Cardiomyopathy (non specified)
23
Renal failure
22
History of myocardial infarction
15
LV dysfunction
14
Coronary spasm
13
Hepatic dysfunction
12
Arrhytmias
9
Inflammatory disease
9
Dyslipidaemia
8
Left bundel branch block
8
Cardiac disease (non specified)
7
Gastro Intestinal disorder
7
Systemic disease (non specified)
6
Smoking
6
Thyroid dysfunction
5
Obesitas
5
Non-cardiac chest pain
5
Condunction disorder (incl LBTB)
5 (13)
Hypertrophic CMP (total CMP)
5 (23)
Congestive CMP (total CMP)
5 (23)
Dilated CMP (CMP total)
4 (23)
Alcoholism
4
Metabolic syndrome
4
Dysphagia/oesophagitis
3
Malignancy
3
LVEF < 40%
2
Psychiatric ilness
2
Auto immune disease
2
Estrogen replacement therapy
2
PTCA/CABG in history
2
Ectasia on CAG
2
Bridging on CAG
2
Claudicatio intermittens
2
Heart failure (non specfied) (total)
1 (17)
Myocarditis
1
Congenital heart disease
1
Aortic wall diseases
1
Anaemia
1
Thrombocytopenia
1
In overviews and textbooks it is often stated that (pre-menopausal) women are especially prone to develop cardiac syndrome X.
In Table 3 data of individual studies are presented.
Table 3
Included studies of CSX patients
Included study of CSX patients
Year
n
Female (%)
Mean age (Y)
Lee [41]
2008
21
81
55
Timurkaynak [61]
2008
79
54
50
Cemin [11]
2008
11
100
59
Zorc-Pleskovic [66]
2008
31
100
55
Lanza [38]
2008
18
61
58
Altun [2]
2007
9
77
49
Cotrim [12]
2008
91
48
51
Asbury [5]
2008
64
100
58
Demir [18]
2008
17
41
57
Grabczewska [23]
2007
53
57
55
Li [44]
2007
36
100
NA
Okyay [48]
2007
32
66
53
Dabek [15]
2007
34
65
57
Yildiz [64]
2007
10
79
49
Kayikcioglu [33]
2007
30
60
46
Mao [45]
2007
51
78
21
Dabek [14]
2007
36
65
57
Vermeltfoort [63]
2007
20
75
55
Galiuto [21]
2007
17
53
55
Alroy [1]
2007
42
100
52
Huang [29]
2007
12
60
63
Guzik [28]
2007
43
65
44
Gur [26]
2007
23
70
49
Gur [27]
2007
23
NA
NA
Sgueglia [59]
2007
30
73
61
Russell [55]
2007
24
89
54
Sen [56]
2007
203
58
53
Shmilovich [60]
2007
17
71
58
de Vries [17]
2006
42
26
58
Nam [47]
2006
52
NA
NA
Eskandarian [19]
2006
40
73
46
Cay [10]
2006
126
62
53
Jadhav [30]
2006
52
100
56
Czepczynski [13]
2006
68
63
45
Leu [43]
2006
92
21
64
Lanza [40]
2005
10
59
70
Cay [9]
2005
80
52
51
On [49]
2005
36
53
36
Guo [25]
2005
22
68
48
Masci [46]
2005
41
NA
53
Senen [57]
2005
21
48
56
Pasqui [51]
2005
30
60
54
Sestito [58]
2005
30
73
60
De Candia [16]
2005
21
57
55
Valeriani [62]
2005
16
50
60
Cavusoglu [8]
2005
31
45
52
Kolasinska-Kloch [36]
2004
42
52
46
Kolasilska-Kloch [35]
2004
25
36
49
Altun [3]
2004
8
75
46
Asbury [4]
2004
100
100
61
Fabian [20]
2004
40
40
55
Lanza [39]
2004
55
50
57
Qian [54]
2004
126
47
53
Osamichi [50]
2004
24
71
58
Gorgulu [22]
2003
18
44
51
Pizzi [53]
2004
NA
NA
59
Kidawa [34]
2003
50
64
49
NA not available
In 53 out of the total of 57 included studies the female/male distribution of the study population was mentioned. Six studies were focussed upon female patients with CSX. These studies were excluded for the pooling of the proportion of women in the study populations. Ultimately 47 studies with a total of 1,934 patients could be used for the meta-analysis.
The proportion of women in the 47 studies of CSX patients varied considerably ranging from 0.21 to 1.0, with a pooled estimate of 0.56 (95% confidence interval: 0.54–0.59), see also Fig. 1. Hence, there is a significantly higher proportion of woman compared to males in the group of patients with CSX.

CSX incidence

As much as 567 CAGs were performed in 1 year at a general hospital. Figure 2 is a flowchart showing how we analysed the available information. The main stages are:
  • Original CAGs or clinical data could not be found for eight patients, leaving 559 cases for analysis.
  • Out of the available 559 CAGs 78 (14%) were considered as absolutely normal.
  • Excluding 13 cases with no angina pectoris as indication for CAG, and another 5 with an acute coronary syndrome, resulted in an incidence of 60 (11%) CSX patients according to the broad diagnosis of CSX (angina pectoris and normal coronary arteries) [17, 23, 54, 65, 66].
  • Another 15 cases were excluded owing to the lack of exercise stress tests or myocardial perfusion imaging preceding the CAG.
  • Of the remaining 45 cases, 28 were included owing to positive results for ischaemia from exercise tests or SPECT.
  • Finally, a much stricter definition of CSX was obtained by using the main exclusion criteria shown in the second-to-last stage in Fig. 2. This strict definition resulted in an attributable CSX incidence of 18 (3%) patients.

Discussion

CSX definitions and incidences

The present review of recent archival literature demonstrates that there is a wide range of definitions of CSX. This wide range of definitions has a large effect on the attributable incidence of CSX, as has been shown by an analysis of all available CAGs and other clinical data for a population of patients treated in 1 year at a general hospital.
Generally, it is stated that patients with chest pain and normal coronary arteriogram may represent 10–20% of those undergoing coronary arteriography because of clinical suspicion of angina [65]. This is in broad agreement with our analysis results that 11% of patients had a normal CAG. The rather low incidence of normal CAG can be the result of the use of rather strict criteria for a normal CAG including a consensus reading by two independent readers of the CAG’s.
It is generally accepted (e.g. in authoritative textbooks) that the majority of the CSX patients are women [32, 65]. Some authors have even suggested that CSX is a women’s disease. However, our review has found a pooled relative female frequency of 56% in a population of more than 1,900 CSX patients. Thus, our data do not support the assumption that CSX is a women’s disease, since 44% of the population was male. Potential pathophysiological explanations, such as estrogen depletion, which are based upon the female gender, apply only to a part of the CSX patients [31].

Inclusion and exclusion criteria

The literature survey showed that the inclusion and exclusion criteria varied. This was especially the case for the exclusion criteria.
The definition of ‘normal coronary arteries’ was particularly unclear. Most studies did not define a normal CAG, and some included patients with coronary artery disease (CAD) ranging from minimal to stenoses up to 50% of luminal diameter. Obviously, normal coronary arteries are the cornerstone of the diagnosis of CSX. Hence, there should be no doubt regarding the use of this inclusion criterion for studies of CSX patients. Future studies of CSX patients should make a clear description regarding the evaluation and results of the CAG studies of the coronary artery anatomy.
The so-called broad diagnosis for CSX, a combination of 2 inclusion criteria (angina pectoris and normal coronary arteries) was used only in four studies (7%).
Most studies used a combination of three inclusion criteria, namely (effort induced) angina pectoris, positive exercise test result, and a normal CAG. This definition was used in 46 out of 57 studies (81%). The use of this additional inclusion criterion resulted in a decrease of the incidence of CSX to 7% in our population. The definition of a positive exercise stress test appears to be more standardized than the definition of a normal CAG. Most publications used a ST depression ≥1 mm as a positive exercise stress test: only 12 out of the 57 studies did not define a positive stress test.
The use of specific exclusion criteria ranged from 2 to 58% of the selected studies of CSX patients, often depending on the main objectives of the studies, for example the use of thrombocytopenia as an exclusion criterion in a study investigating the mean platelet volume [9].
The most frequently mentioned exclusion criteria are valvular heart disease, diabetes mellitus, left ventricular hypertrophy, hypertension, and cardiomyopathy. Endothelial dysfunction has been assessed both in patients with diabetes mellitus and hypertension with normal CAG, and in patients with CSX without diabetes or hypertension. Interestingly, coronary flow reserve may be reversible in specific patient groups, e.g. in patients with hypertrophy after anti-hypertensive therapy [52]. However, we note that most international studies consider diabetes mellitus and hypertension to be exclusion criteria for CSX, thereby considering these patients as a separate group.
The existence of such a long list of exclusion criteria in the selection process of CSX patients illustrates the lack of agreement between the different research groups regarding the origins of this syndrome. Besides the use of a standard and fixed combination of inclusion criteria future studies should apply a standard combination of exclusion criteria.
In a recent editorial, Camici proposed the following exclusion criteria in order to obtain a more homogeneous set of cardiac syndrome X patients: absence of left bundle branch block; absence of even minimal irregularities on the angiogram; no evidence of diabetes mellitus, arterial hypertension, hyperlipidaemia, valve disease, epicardial arterial spasm, and cardiomyopathy [7].
In our selection of CSX patients we decided to include only patients with completely normal coronary angiograms, effort-induced angina pectoris, positive exercise stress test and/or positive SPECT study. Furthermore, we decided to add arrhythmias, left ventricular hypertrophy, myocardial infarction in the medical history, and myocardial bridging to the exclusion criteria proposed by Camici. These inclusion and exclusion criteria resulted in an attributable CSX incidence of only 3%.

Conclusions

The wide range of definitions of CSX in recent literature and the variations in inclusion and exclusion criteria, particularly the latter, make interpretation of the results of individual studies difficult. This shows the need for a generally accepted definition of CSX.

Acknowledgments

We thank Dr. R.J.H. Wanhill for his critical review and editing of the manuscript.

Conflict of interest statement

None.

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Open AccessThis is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://​creativecommons.​org/​licenses/​by-nc/​2.​0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Unsere Produktempfehlungen

Neuer Inhalt

Print-Titel

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Alroy S, Preis M, Barzilai M et al (2007) Endothelial cell dysfunction in women with cardiac syndrome X and MTHFR C677T mutation. Isr Med Assoc J 9:321–325PubMed Alroy S, Preis M, Barzilai M et al (2007) Endothelial cell dysfunction in women with cardiac syndrome X and MTHFR C677T mutation. Isr Med Assoc J 9:321–325PubMed
2.
Zurück zum Zitat Altun A, Turgut N, Tatli E et al (2007) Sympathetic skin response and RR interval variation in patients with cardiac syndrome X. Angiology 58:747–750CrossRefPubMed Altun A, Turgut N, Tatli E et al (2007) Sympathetic skin response and RR interval variation in patients with cardiac syndrome X. Angiology 58:747–750CrossRefPubMed
3.
Zurück zum Zitat Altun A, Ugur-Altun B, Tatli E (2004) Decreased serum osteoprotegerin levels in patients with cardiac syndrome X. J Endocrinol Invest 27:839–843PubMed Altun A, Ugur-Altun B, Tatli E (2004) Decreased serum osteoprotegerin levels in patients with cardiac syndrome X. J Endocrinol Invest 27:839–843PubMed
4.
Zurück zum Zitat Asbury EA, Creed F, Collins P (2004) Distinct psychosocial differences between women with coronary heart disease and cardiac syndrome X. Eur Heart J 25:1695–1701CrossRefPubMed Asbury EA, Creed F, Collins P (2004) Distinct psychosocial differences between women with coronary heart disease and cardiac syndrome X. Eur Heart J 25:1695–1701CrossRefPubMed
5.
Zurück zum Zitat Asbury EA, Slattery C, Grant A et al (2008) Cardiac rehabilitation for the treatment of women with chest pain and normal coronary arteries. Menopause 15:454–460CrossRefPubMed Asbury EA, Slattery C, Grant A et al (2008) Cardiac rehabilitation for the treatment of women with chest pain and normal coronary arteries. Menopause 15:454–460CrossRefPubMed
6.
Zurück zum Zitat Athanasiadis A, Vogelsberg H, Hauer B et al (2006) Transient left ventricular dysfunction with apical ballooning (tako-tsubo cardiomyopathy) in Germany. Clin Res Cardiol 95:321–328CrossRefPubMed Athanasiadis A, Vogelsberg H, Hauer B et al (2006) Transient left ventricular dysfunction with apical ballooning (tako-tsubo cardiomyopathy) in Germany. Clin Res Cardiol 95:321–328CrossRefPubMed
7.
Zurück zum Zitat Camici PG (2007) Is the chest pain in cardiac syndrome X due to subendocardial ischaemia? Eur Heart J 28:1539–1540CrossRefPubMed Camici PG (2007) Is the chest pain in cardiac syndrome X due to subendocardial ischaemia? Eur Heart J 28:1539–1540CrossRefPubMed
8.
Zurück zum Zitat Cavusoglu Y, Entok E, Timuralp B et al (2005) Regional distribution and extent of perfusion abnormalities, and the lung to heart uptake ratios during exercise thallium-201 SPECT imaging in patients with cardiac syndrome X. Can J Cardiol 21:57–62PubMed Cavusoglu Y, Entok E, Timuralp B et al (2005) Regional distribution and extent of perfusion abnormalities, and the lung to heart uptake ratios during exercise thallium-201 SPECT imaging in patients with cardiac syndrome X. Can J Cardiol 21:57–62PubMed
9.
Zurück zum Zitat Cay S, Biyikoglu F, Cihan G et al (2005) Mean platelet volume in the patients with cardiac syndrome X. J Thromb Thrombolysis 20:175–178CrossRefPubMed Cay S, Biyikoglu F, Cihan G et al (2005) Mean platelet volume in the patients with cardiac syndrome X. J Thromb Thrombolysis 20:175–178CrossRefPubMed
10.
Zurück zum Zitat Cay S, Guray U, Korkmaz S (2006) Increased aortic pulse and fractional pulse pressures in patients with cardiac syndrome X. Blood Press 15:179–184CrossRefPubMed Cay S, Guray U, Korkmaz S (2006) Increased aortic pulse and fractional pulse pressures in patients with cardiac syndrome X. Blood Press 15:179–184CrossRefPubMed
11.
Zurück zum Zitat Cemin R, Erlicher A, Fattor B et al (2008) Reduced coronary flow reserve and parasympathetic dysfunction in patients with cardiovascular syndrome X. Coron Artery Dis 19:1–7CrossRefPubMed Cemin R, Erlicher A, Fattor B et al (2008) Reduced coronary flow reserve and parasympathetic dysfunction in patients with cardiovascular syndrome X. Coron Artery Dis 19:1–7CrossRefPubMed
12.
Zurück zum Zitat Cotrim C, Almeida AG, Carrageta M (2008) Exercise-induced intra-ventricular gradients as a frequent potential cause of myocardial ischemia in cardiac syndrome X patients. Cardiovasc Ultrasound 6:3CrossRefPubMed Cotrim C, Almeida AG, Carrageta M (2008) Exercise-induced intra-ventricular gradients as a frequent potential cause of myocardial ischemia in cardiac syndrome X patients. Cardiovasc Ultrasound 6:3CrossRefPubMed
13.
Zurück zum Zitat Czepczynski R, Smolarek I, Rogacka D et al (2006) Myocardial perfusion SPECT with dipyridamole stress test in cardiac syndrome X. Nuklearmedizin 45:111–114PubMed Czepczynski R, Smolarek I, Rogacka D et al (2006) Myocardial perfusion SPECT with dipyridamole stress test in cardiac syndrome X. Nuklearmedizin 45:111–114PubMed
14.
Zurück zum Zitat Dabek J, Kulach A, Wilczok T et al (2007) Transcriptional activity of genes encoding interferon gamma (IFNgamma) and its receptor assessed in peripheral blood mononuclear cells in patients with cardiac syndrome X. Inflammation 30:125–129CrossRefPubMed Dabek J, Kulach A, Wilczok T et al (2007) Transcriptional activity of genes encoding interferon gamma (IFNgamma) and its receptor assessed in peripheral blood mononuclear cells in patients with cardiac syndrome X. Inflammation 30:125–129CrossRefPubMed
15.
Zurück zum Zitat Dabek J, Wilczok T, Gasior Z et al (2007) Gene expression of kinin receptors B1 and B2 in PBMC from patients with cardiac syndrome X. Scand Cardiovasc J 41:391–396CrossRefPubMed Dabek J, Wilczok T, Gasior Z et al (2007) Gene expression of kinin receptors B1 and B2 in PBMC from patients with cardiac syndrome X. Scand Cardiovasc J 41:391–396CrossRefPubMed
16.
Zurück zum Zitat De Candia E, Lanza GA, Romagnoli E et al (2005) Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X. Int J Cardiol 100:371–376CrossRefPubMed De Candia E, Lanza GA, Romagnoli E et al (2005) Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X. Int J Cardiol 100:371–376CrossRefPubMed
17.
Zurück zum Zitat de Vries J, DeJongste MJ, Jessurun GA et al (2006) Myocardial perfusion quantification in patients suspected of cardiac syndrome X with positive and negative exercise testing: a [13N]ammonia positron emission tomography study. Nucl Med Commun 27:791–794CrossRefPubMed de Vries J, DeJongste MJ, Jessurun GA et al (2006) Myocardial perfusion quantification in patients suspected of cardiac syndrome X with positive and negative exercise testing: a [13N]ammonia positron emission tomography study. Nucl Med Commun 27:791–794CrossRefPubMed
18.
Zurück zum Zitat Demir H, Kahraman G, Isgoren S et al (2008) Evaluation of post-stress left ventricular dysfunction and its relationship with perfusion abnormalities using gated SPECT in patients with cardiac syndrome X. Nucl Med Commun 29:208–214CrossRefPubMed Demir H, Kahraman G, Isgoren S et al (2008) Evaluation of post-stress left ventricular dysfunction and its relationship with perfusion abnormalities using gated SPECT in patients with cardiac syndrome X. Nucl Med Commun 29:208–214CrossRefPubMed
19.
Zurück zum Zitat Eskandarian R, Malek M, Mousavi SH et al (2006) Association of Helicobacter pylori infection with cardiac syndrome X. Singapore Med J 47:704–706PubMed Eskandarian R, Malek M, Mousavi SH et al (2006) Association of Helicobacter pylori infection with cardiac syndrome X. Singapore Med J 47:704–706PubMed
20.
Zurück zum Zitat Fabian E, Varga A, Picano E et al (2004) Effect of simvastatin on endothelial function in cardiac syndrome X patients. Am J Cardiol 94:652–655CrossRefPubMed Fabian E, Varga A, Picano E et al (2004) Effect of simvastatin on endothelial function in cardiac syndrome X patients. Am J Cardiol 94:652–655CrossRefPubMed
21.
Zurück zum Zitat Galiuto L, Sestito A, Barchetta S et al (2007) Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X. Am J Cardiol 99:1378–1383CrossRefPubMed Galiuto L, Sestito A, Barchetta S et al (2007) Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X. Am J Cardiol 99:1378–1383CrossRefPubMed
22.
Zurück zum Zitat Gorgulu S, Uslu N, Eren M et al (2003) Aortic stiffness in patients with cardiac syndrome X. Acta Cardiol 58:507–511CrossRefPubMed Gorgulu S, Uslu N, Eren M et al (2003) Aortic stiffness in patients with cardiac syndrome X. Acta Cardiol 58:507–511CrossRefPubMed
23.
Zurück zum Zitat Grabczewska Z, Thews M, Goralczyk K et al (2007) Endothelial function in patients with chest pain and normal coronary angiograms. Kardiol Pol 65:1199–1206PubMed Grabczewska Z, Thews M, Goralczyk K et al (2007) Endothelial function in patients with chest pain and normal coronary angiograms. Kardiol Pol 65:1199–1206PubMed
24.
Zurück zum Zitat Grawe H, Katoh M, Kuhl HP (2006) Stress cardiomyopathy mimicking acute coronary syndrome: case presentation and review of the literature. Clin Res Cardiol 95:179–185CrossRefPubMed Grawe H, Katoh M, Kuhl HP (2006) Stress cardiomyopathy mimicking acute coronary syndrome: case presentation and review of the literature. Clin Res Cardiol 95:179–185CrossRefPubMed
25.
Zurück zum Zitat Guo H, Lee JD, Guo M et al (2005) Status of intracellular and extracellular magnesium concentration in patients with cardiac syndrome X. Acta Cardiol 60:259–263CrossRefPubMed Guo H, Lee JD, Guo M et al (2005) Status of intracellular and extracellular magnesium concentration in patients with cardiac syndrome X. Acta Cardiol 60:259–263CrossRefPubMed
26.
Zurück zum Zitat Gur M, Yildiz A, Demirbag R et al (2007) Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers. Coron Artery Dis 18:89–95CrossRefPubMed Gur M, Yildiz A, Demirbag R et al (2007) Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers. Coron Artery Dis 18:89–95CrossRefPubMed
27.
Zurück zum Zitat Gur M, Yildiz A, Demirbag R et al (2007) Increased lymphocyte deoxyribonucleic acid damage in patients with cardiac syndrome X. Mutat Res 617:8–15PubMed Gur M, Yildiz A, Demirbag R et al (2007) Increased lymphocyte deoxyribonucleic acid damage in patients with cardiac syndrome X. Mutat Res 617:8–15PubMed
28.
Zurück zum Zitat Guzik P, Rogacka D, Trachalski J et al (2007) Comparison of the exercise treadmill test and 24-hour ECG Holter monitoring in patients with syndrome X or coronary atherosclerosis. Kardiol Pol 65:262–269PubMed Guzik P, Rogacka D, Trachalski J et al (2007) Comparison of the exercise treadmill test and 24-hour ECG Holter monitoring in patients with syndrome X or coronary atherosclerosis. Kardiol Pol 65:262–269PubMed
29.
Zurück zum Zitat Huang PH, Chen YH, Chen YL et al (2007) Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart 93:1064–1070CrossRefPubMed Huang PH, Chen YH, Chen YL et al (2007) Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart 93:1064–1070CrossRefPubMed
30.
Zurück zum Zitat Jadhav ST, Ferrell WR, Petrie JR et al (2006) Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X. Am J Cardiol 97:1727–1731CrossRefPubMed Jadhav ST, Ferrell WR, Petrie JR et al (2006) Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X. Am J Cardiol 97:1727–1731CrossRefPubMed
31.
Zurück zum Zitat Kaski JC (2006) Cardiac syndrome X in women: the role of oestrogen deficiency. Heart 92(Suppl 3):iii5–iii9CrossRefPubMed Kaski JC (2006) Cardiac syndrome X in women: the role of oestrogen deficiency. Heart 92(Suppl 3):iii5–iii9CrossRefPubMed
32.
Zurück zum Zitat Kaski JC (2002) Overview of gender aspects of cardiac syndrome X. Cardiovasc Res 53:620–626CrossRefPubMed Kaski JC (2002) Overview of gender aspects of cardiac syndrome X. Cardiovasc Res 53:620–626CrossRefPubMed
33.
Zurück zum Zitat Kayikcioglu M, Saygi S, Azarsiz E et al (2007) Serum paraoxonase 1 activity and oxidative markers of LDL in patients with cardiac syndrome X. Acta Cardiol 62:245–249CrossRefPubMed Kayikcioglu M, Saygi S, Azarsiz E et al (2007) Serum paraoxonase 1 activity and oxidative markers of LDL in patients with cardiac syndrome X. Acta Cardiol 62:245–249CrossRefPubMed
34.
Zurück zum Zitat Kidawa M, Krzeminska-Pakula M, Peruga JZ et al (2003) Cardiological syndrome X Non-invasive assessment of endothelial function and arterial compliance. Kardiol Pol 59:385–396PubMed Kidawa M, Krzeminska-Pakula M, Peruga JZ et al (2003) Cardiological syndrome X Non-invasive assessment of endothelial function and arterial compliance. Kardiol Pol 59:385–396PubMed
35.
Zurück zum Zitat Kolasilska-Kloch W, Lesniak W, Leszczynska-Golabek I et al (2004) Exercise tolerance and hyperinsulinemia in cardiac syndrome X. Folia Med Cracov 45:13–23PubMed Kolasilska-Kloch W, Lesniak W, Leszczynska-Golabek I et al (2004) Exercise tolerance and hyperinsulinemia in cardiac syndrome X. Folia Med Cracov 45:13–23PubMed
36.
Zurück zum Zitat Kolasinska-Kloch W, Furgala A, Krolczyk G et al (2004) Cardiac syndrome X-autonomic system disorders. Folia Med Cracov 45:19–29PubMed Kolasinska-Kloch W, Furgala A, Krolczyk G et al (2004) Cardiac syndrome X-autonomic system disorders. Folia Med Cracov 45:19–29PubMed
37.
Zurück zum Zitat Lanza GA (2007) Cardiac syndrome X: a critical overview and future perspectives. Heart 93:159–166CrossRefPubMed Lanza GA (2007) Cardiac syndrome X: a critical overview and future perspectives. Heart 93:159–166CrossRefPubMed
38.
Zurück zum Zitat Lanza GA, Buffon A, Sestito A et al (2008) Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J Am Coll Cardiol 51:466–472CrossRefPubMed Lanza GA, Buffon A, Sestito A et al (2008) Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J Am Coll Cardiol 51:466–472CrossRefPubMed
39.
Zurück zum Zitat Lanza GA, Sestito A, Cammarota G et al (2004) Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. Am J Cardiol 94:40–44CrossRefPubMed Lanza GA, Sestito A, Cammarota G et al (2004) Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. Am J Cardiol 94:40–44CrossRefPubMed
40.
Zurück zum Zitat Lanza GA, Sestito A, Sgueglia GA et al (2005) Effect of spinal cord stimulation on spontaneous and stress-induced angina and ‘ischemia-like’ ST-segment depression in patients with cardiac syndrome X. Eur Heart J 26:983–989CrossRefPubMed Lanza GA, Sestito A, Sgueglia GA et al (2005) Effect of spinal cord stimulation on spontaneous and stress-induced angina and ‘ischemia-like’ ST-segment depression in patients with cardiac syndrome X. Eur Heart J 26:983–989CrossRefPubMed
41.
Zurück zum Zitat Lee BK, Durairaj A, Mehra A et al (2008) Microcirculatory dysfunction in cardiac syndrome X: role of abnormal blood rheology. Microcirculation 15:451–459CrossRefPubMed Lee BK, Durairaj A, Mehra A et al (2008) Microcirculatory dysfunction in cardiac syndrome X: role of abnormal blood rheology. Microcirculation 15:451–459CrossRefPubMed
42.
Zurück zum Zitat Leichman JG, Lavis VR, Aguilar D et al (2006) The metabolic syndrome and the heart—a considered opinion. Clin Res Cardiol 95(Suppl 1):i134–i141CrossRefPubMed Leichman JG, Lavis VR, Aguilar D et al (2006) The metabolic syndrome and the heart—a considered opinion. Clin Res Cardiol 95(Suppl 1):i134–i141CrossRefPubMed
43.
Zurück zum Zitat Leu HB, Lin CP, Lin WT et al (2006) Circulating mononuclear superoxide production and inflammatory markers for long-term prognosis in patients with cardiac syndrome X. Free Radic Biol Med 40:983–991CrossRefPubMed Leu HB, Lin CP, Lin WT et al (2006) Circulating mononuclear superoxide production and inflammatory markers for long-term prognosis in patients with cardiac syndrome X. Free Radic Biol Med 40:983–991CrossRefPubMed
44.
Zurück zum Zitat Li JJ, Zhu CG, Nan JL et al (2007) Elevated circulating inflammatory markers in female patients with cardiac syndrome X. Cytokine 40:172–176CrossRefPubMed Li JJ, Zhu CG, Nan JL et al (2007) Elevated circulating inflammatory markers in female patients with cardiac syndrome X. Cytokine 40:172–176CrossRefPubMed
45.
Zurück zum Zitat Mao JY, Ge YB, Wang HH et al (2007) Summary of 32 patients with cardiac syndrome X treated by TCM therapy of regulating qi relieving chest stuffiness and promoting blood circulation. Chin J Integr Med 13:17–21CrossRefPubMed Mao JY, Ge YB, Wang HH et al (2007) Summary of 32 patients with cardiac syndrome X treated by TCM therapy of regulating qi relieving chest stuffiness and promoting blood circulation. Chin J Integr Med 13:17–21CrossRefPubMed
46.
Zurück zum Zitat Masci PG, Laclaustra M, Lara JG et al (2005) Brachial artery flow-mediated dilation and myocardial perfusion in patients with cardiac syndrome X. Am J Cardiol 95:1478–1480CrossRefPubMed Masci PG, Laclaustra M, Lara JG et al (2005) Brachial artery flow-mediated dilation and myocardial perfusion in patients with cardiac syndrome X. Am J Cardiol 95:1478–1480CrossRefPubMed
47.
Zurück zum Zitat Nam CW, Kim KS, Lee YS et al (2006) The incidence of gastro-esophageal disease for the patients with typical chest pain and a normal coronary angiogram. Korean J Intern Med 21:94–96PubMed Nam CW, Kim KS, Lee YS et al (2006) The incidence of gastro-esophageal disease for the patients with typical chest pain and a normal coronary angiogram. Korean J Intern Med 21:94–96PubMed
48.
Zurück zum Zitat Okyay K, Cengel A, Sahinarslan A et al (2007) Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X. Coron Artery Dis 18:539–544CrossRefPubMed Okyay K, Cengel A, Sahinarslan A et al (2007) Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X. Coron Artery Dis 18:539–544CrossRefPubMed
49.
Zurück zum Zitat On YK, Park R, Hyon MS et al (2005) Are low total serum antioxidant status and elevated levels of C-reactive protein and monocyte chemotactic protein-1 associated with cardiac syndrome X? Circ J 69:1212–1217CrossRefPubMed On YK, Park R, Hyon MS et al (2005) Are low total serum antioxidant status and elevated levels of C-reactive protein and monocyte chemotactic protein-1 associated with cardiac syndrome X? Circ J 69:1212–1217CrossRefPubMed
50.
Zurück zum Zitat Osamichi S, Kouji K, Yoshimaro I et al (2004) Myocardial glucose metabolism assessed by positron emission tomography and the histopathologic findings of microvessels in syndrome X. Circ J 68:220–226CrossRefPubMed Osamichi S, Kouji K, Yoshimaro I et al (2004) Myocardial glucose metabolism assessed by positron emission tomography and the histopathologic findings of microvessels in syndrome X. Circ J 68:220–226CrossRefPubMed
51.
Zurück zum Zitat Pasqui AL, Puccetti L, Di Renzo M et al (2005) Structural and functional abnormality of systemic microvessels in cardiac syndrome X. Nutr Metab Cardiovasc Dis 15:56–64CrossRefPubMed Pasqui AL, Puccetti L, Di Renzo M et al (2005) Structural and functional abnormality of systemic microvessels in cardiac syndrome X. Nutr Metab Cardiovasc Dis 15:56–64CrossRefPubMed
52.
Zurück zum Zitat Petkow Dimitrow P, Krzanowski M, Nizankowski R et al (2000) Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Heart 83:262–266CrossRefPubMed Petkow Dimitrow P, Krzanowski M, Nizankowski R et al (2000) Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Heart 83:262–266CrossRefPubMed
53.
Zurück zum Zitat Pizzi C, Manfrini O, Fontana F et al (2004) Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X: role of superoxide dismutase activity. Circulation 109:53–58CrossRefPubMed Pizzi C, Manfrini O, Fontana F et al (2004) Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X: role of superoxide dismutase activity. Circulation 109:53–58CrossRefPubMed
54.
Zurück zum Zitat Qian JY, Ge JB, Fan B et al (2004) Identification of syndrome X using intravascular ultrasound imaging and Doppler flow mapping. Chin Med J (Engl) 117:521–527 Qian JY, Ge JB, Fan B et al (2004) Identification of syndrome X using intravascular ultrasound imaging and Doppler flow mapping. Chin Med J (Engl) 117:521–527
55.
Zurück zum Zitat Russell SJ, Di Stefano EM, Naffati MT et al (2007) The effects of the angiotensin II receptor (type I) antagonist irbesartan in patients with cardiac syndrome X. Heart 93:253–254CrossRefPubMed Russell SJ, Di Stefano EM, Naffati MT et al (2007) The effects of the angiotensin II receptor (type I) antagonist irbesartan in patients with cardiac syndrome X. Heart 93:253–254CrossRefPubMed
56.
Zurück zum Zitat Sen N, Tavil Y, Yazici HU et al (2007) Coronary blood flow in patients with cardiac syndrome X. Coron Artery Dis 18:45–48CrossRefPubMed Sen N, Tavil Y, Yazici HU et al (2007) Coronary blood flow in patients with cardiac syndrome X. Coron Artery Dis 18:45–48CrossRefPubMed
57.
Zurück zum Zitat Senen K, Ileri M, Alper A et al (2005) Increased levels of soluble adhesion molecules E-selectin and P-selectin in patients with cardiac syndrome X. Angiology 56:273–277CrossRefPubMed Senen K, Ileri M, Alper A et al (2005) Increased levels of soluble adhesion molecules E-selectin and P-selectin in patients with cardiac syndrome X. Angiology 56:273–277CrossRefPubMed
58.
Zurück zum Zitat Sestito A, Maccallini A, Sgueglia GA et al (2005) Platelet reactivity in response to mental stress in syndrome X and in stable or unstable coronary artery disease. Thromb Res 116:25–31CrossRefPubMed Sestito A, Maccallini A, Sgueglia GA et al (2005) Platelet reactivity in response to mental stress in syndrome X and in stable or unstable coronary artery disease. Thromb Res 116:25–31CrossRefPubMed
59.
Zurück zum Zitat Sgueglia GA, Sestito A, Spinelli A et al (2007) Long-term follow-up of patients with cardiac syndrome X treated by spinal cord stimulation. Heart 93:591–597CrossRefPubMed Sgueglia GA, Sestito A, Spinelli A et al (2007) Long-term follow-up of patients with cardiac syndrome X treated by spinal cord stimulation. Heart 93:591–597CrossRefPubMed
60.
Zurück zum Zitat Shmilovich H, Deutsch V, Roth A et al (2007) Circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart 93:1071–1076CrossRefPubMed Shmilovich H, Deutsch V, Roth A et al (2007) Circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart 93:1071–1076CrossRefPubMed
61.
Zurück zum Zitat Timurkaynak T, Balcioglu S, Arslan U et al (2008) Plasma homocysteine level in cardiac syndrome X and its relation with duke treadmill score. Saudi Med J 29:364–367PubMed Timurkaynak T, Balcioglu S, Arslan U et al (2008) Plasma homocysteine level in cardiac syndrome X and its relation with duke treadmill score. Saudi Med J 29:364–367PubMed
62.
Zurück zum Zitat Valeriani M, Sestito A, Le Pera D et al (2005) Abnormal cortical pain processing in patients with cardiac syndrome X. Eur Heart J 26:975–982CrossRefPubMed Valeriani M, Sestito A, Le Pera D et al (2005) Abnormal cortical pain processing in patients with cardiac syndrome X. Eur Heart J 26:975–982CrossRefPubMed
63.
Zurück zum Zitat Vermeltfoort IA, Bondarenko O, Raijmakers PG et al (2007) Is subendocardial ischaemia present in patients with chest pain and normal coronary angiograms? A cardiovascular MR study. Eur Heart J 28:1554–1558CrossRefPubMed Vermeltfoort IA, Bondarenko O, Raijmakers PG et al (2007) Is subendocardial ischaemia present in patients with chest pain and normal coronary angiograms? A cardiovascular MR study. Eur Heart J 28:1554–1558CrossRefPubMed
64.
Zurück zum Zitat Yildiz M, Altun A, Ozbay G (2007) Assessment of arterial distensibility in patients with cardiac syndrome X. Angiology 58:458–462CrossRefPubMed Yildiz M, Altun A, Ozbay G (2007) Assessment of arterial distensibility in patients with cardiac syndrome X. Angiology 58:458–462CrossRefPubMed
65.
Zurück zum Zitat Zipes DP, Libby P, Bonow RO et al (2008) Braunwald’s heart disease: a textbook of cardiovascular medicine, 8 edn. Saunders-Elsevier, Philadelphia Zipes DP, Libby P, Bonow RO et al (2008) Braunwald’s heart disease: a textbook of cardiovascular medicine, 8 edn. Saunders-Elsevier, Philadelphia
66.
Zurück zum Zitat Zorc-Pleskovic R, Vraspir-Porenta O, Zorc M et al (2008) Inflammatory changes in small blood vessels in the endomyocardium of cardiac syndrome X in female patients with increased C-reactive protein. Folia Biol (Praha) 54:30–32 Zorc-Pleskovic R, Vraspir-Porenta O, Zorc M et al (2008) Inflammatory changes in small blood vessels in the endomyocardium of cardiac syndrome X in female patients with increased C-reactive protein. Folia Biol (Praha) 54:30–32
Metadaten
Titel
Definitions and incidence of cardiac syndrome X: review and analysis of clinical data
verfasst von
I. A. C. Vermeltfoort
P. G. H. M. Raijmakers
I. I. Riphagen
D. A. M. Odekerken
A. F. M. Kuijper
A. Zwijnenburg
G. J. J. Teule
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
Clinical Research in Cardiology / Ausgabe 8/2010
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-010-0159-1

Weitere Artikel der Ausgabe 8/2010

Clinical Research in Cardiology 8/2010 Zur Ausgabe

Letter to the Editor

Galectin 3 in heart failure

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.